Unbiased News Awaits.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
Social Media
Natural Disasters
Unemployment
Stock Markets
European Union
Taxes
World Cup
Work
Senate
Kremlin
Education
Published • loading... • Updated

PEACE-3 Data for Radium-223/enzalutamide Published in Annals of Oncology

Summary by urologytimes.com
The addition of Ra223 to enzalutamide was associated with a 31% reduction in the risk of progression or death compared with enzalutamide alone.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
urologytimes.comurologytimes.com

PEACE-3 data for radium-223/enzalutamide published in Annals of Oncology

The addition of Ra223 to enzalutamide was associated with a 31% reduction in the risk of progression or death compared with enzalutamide alone.

Read Full Article
The Standard-JournalThe Standard-Journal

New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology

WHIPPANY, N.J.--(BUSINESS WIRE)--May 30, 2025-

·Milton, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Standard-Journal broke the news in Milton, United States on Friday, May 30, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

New Jersey

New Jersey

News
For You
SearchBlindspotLocal